Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Valeant Pharma Prices New $900 Million Debt Offering

Continuing its history of using debt to fund acquisitionsand pay down existing liabilities, Canada-based Valeant Pharmaceuticals (NYSE: VRX  ) announced yesterday that it had increased its senior unsecured notes offering from $850 million to $900 million, and priced the notes due 2021 at 5.625%.

Proceeds from the new notes, according to Valeant, will be used to pay down the recently called 6.5% notes due 2016. The senior debt due 2016 will be paid in its entirety in two phases. The first entails paying off $450 million of the old debt immediately, Valeant said, with the final $465.5 million in notes due 2016 redeemed at the close of Valeant's latest debt issuance. Valeant will utilize either $50 million in cash or tap into its existing credit line to fund the remaining redemption balance.

As of its recently completed 2013 third quarter, Valeant had $17 billion in long-term debt on its balance sheet, up from $10.5 billion at the end of 2012. The increase in debt is due primarily to Valeant's acquisitions year to date, including securing approximately $7 billion in debt to complete its recent $8.7 billion deal for Bausch & Lomb.

The new senior debt offering due 2021 is expected to close on Dec. 2, according to Valeant.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2731225, ~/Articles/ArticleHandler.aspx, 9/30/2016 11:52:31 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,327.23 183.78 1.01%
S&P 500 2,167.51 16.38 0.76%
NASD 5,313.08 43.92 0.83%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 11:36 AM
VRX $25.39 Up +0.34 +1.36%
Valeant Pharmaceut… CAPS Rating: ***